These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 22799442)

  • 1. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
    Lalani J; Rathi M; Lalan M; Misra A
    Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles.
    Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A
    J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
    Patil GB; Surana SJ
    J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
    Joshi SA; Chavhan SS; Sawant KK
    Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.
    Wang H; Jia Y; Hu W; Jiang H; Zhang J; Zhang L
    Pharm Dev Technol; 2013; 18(3):694-700. PubMed ID: 22676257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Lin PI; Wang CC
    Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
    Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
    Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
    Zhou YZ; Alany RG; Chuang V; Wen J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
    Gan CW; Feng SS
    Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
    Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
    Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders.
    Carroll RT; Bhatia D; Geldenhuys W; Bhatia R; Miladore N; Bishayee A; Sutariya V
    J Drug Target; 2010 Nov; 18(9):665-74. PubMed ID: 20158436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
    Yin Y; Chen D; Qiao M; Lu Z; Hu H
    J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.